Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronomic Cyclophosphamide and Methotrexate in Metastatic Osteosarcoma
NCT03063983Phase 2Unknown
- Sponsor
- GRAACC
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, methotrexate in osteosarcoma (OS), sponsored by GRAACC. Status: unknown.
02
Drugs
cyclophosphamidemethotrexate
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT03063983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03063983.